Medicare Enrolled
Dr. Wesleigh Edwards, MD, PHD
Hospitalist Physician · San Diego, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Edwards from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Edwards?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Edwards
Dr. Wesleigh Edwards is a hospitalist physician in San Diego, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Edwards performed 22,052 Medicare services across 774 unique beneficiaries.
Between the years covered by Open Payments, Dr. Edwards received a total of $8,461 from 35 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Edwards is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years in practice
▲ Top 0% volume in CA
$8,461 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,052
Medicare services
Top 0% in CA for hospitalist physician
774
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,756 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 9,526 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 7,020 | $1 | $7 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,520 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,255 | $0 | $3 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
471 | $2 | $15 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
458 | $14 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
258 | $149 | $491 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
216 | $77 | $1,806 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
211 | $120 | $479 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $106 | $350 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
115 | $58 | $236 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
109 | $59 | $232 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
99 | $25 | $100 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
95 | $6 | $39 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
80 | $1 | $6 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
75 | $68 | $1,192 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $12 | $46 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
53 | $23 | $94 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
44 | $26 | $104 |
| New patient office visit, complex (60-74 min) | 42 | $180 | $598 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
33 | $27 | $88 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
29 | $25 | $110 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
29 | $1 | $41 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
25 | $18 | $72 |
| Blood or blood product transfusion The administration of whole blood or specific blood components into a patient's bloodstream. |
24 | $36 | $157 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $10 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
21 | $30 | $118 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
94.3% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,461
Total received (2019-2024)
Avg $1,410/year across 6 years
Top 3% in CA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,000 (70.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,461 (29.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$448
2023
$6,331
2022
$178
2021
$355
2020
$905
2019
$245
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SpringWorks Therapeutics, Inc.
$72
Novartis Pharmaceuticals Corporation
$70
Eisai Inc.
$51
GlaxoSmithKline, LLC.
$50
ABBVIE INC.
$42
AstraZeneca Pharmaceuticals LP
$38
Blueprint Medicines Corporation
$30
Merck Sharp & Dohme LLC
$27
PFIZER INC.
$25
Aadi Bioscience, Inc.
$24
Daiichi Sankyo Inc.
$19
Top 3 companies account for 42.9% of 2024 payments
All-time payments by company (2019-2024) ›
ImmunoGen, Inc.
$6,000
Amgen Inc.
$235
Novartis Pharmaceuticals Corporation
$227
GlaxoSmithKline, LLC.
$194
Merck Sharp & Dohme Corporation
$191
Eisai Inc.
$175
Foundation Medicine, Inc.
$128
Pharmacyclics LLC, An AbbVie Company
$122
Takeda Pharmaceuticals U.S.A., Inc.
$118
AstraZeneca Pharmaceuticals LP
$112
Incyte Corporation
$92
BeiGene USA, Inc.
$82
Alexion Pharmaceuticals, Inc.
$75
SpringWorks Therapeutics, Inc.
$72
GENZYME CORPORATION
$52
Blueprint Medicines Corporation
$45
Astellas Pharma US Inc
$45
PFIZER INC.
$43
ABBVIE INC.
$42
Lilly USA, LLC
$42
Daiichi Sankyo Inc.
$39
E.R. Squibb & Sons, L.L.C.
$31
Seagen Inc.
$28
Merck Sharp & Dohme LLC
$27
Ipsen Biopharmaceuticals, Inc
$26
Acceleron Pharma, Inc.
$25
AMAG Pharmaceuticals, Inc.
$25
Aadi Bioscience, Inc.
$24
Lexicon Pharmaceuticals, Inc.
$24
ADC Therapeutics America, Inc.
$24
Clovis Oncology, Inc.
$23
Exelixis Inc.
$21
Acrotech Biopharma LLC
$20
Dendreon Pharmaceuticals LLC
$16
EMD Serono, Inc.
$16
Top 3 companies account for 76.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BAVENCIO · BLENREP · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CYRAMZA · ELIQUIS · ELITEK · EPKINLY · Elahere · FERAHEME · FOLOTYN · FOUNDATIONONE · Fabhalta · Fyarro · GAVRETO · IMBRUVICA · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · Kyprolis · LENVIMA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Neulasta · Nplate · OGSIVEO · OJJAARA · OPDIVO · PADCEV · PROMACTA · PROVENGE · Reblozyl · Rubraca · SARCLISA · SOMATULINE DEPOT · TABRECTA · TAGRISSO · TASIGNA · TIVDAK · Ultomiris · Vanflyta · XGEVA · XOSPATA · Xermelo · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (71%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for hospitalist physician in CA.
Geographic Context
Hospitalist physicians within 10 mi
173
Per 100K population
5.3
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Edwards is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with consulting-driven industry engagement in the top 3% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Edwards experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Edwards performed 9,526 paclitaxel chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Edwards receive payments from pharmaceutical companies?
Yes. Dr. Edwards received a total of $8,461 from 35 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Edwards's costs compare to other hospitalist physicians in San Diego?
Dr. Edwards's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Edwards) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in San Diego
Browse hospitalist physicians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in CA
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in CA
Which CA hospitalist physicians receive the most from drug and device companies.
By company
ImmunoGen, Inc. Payments to Doctors
See all physicians who received payments from ImmunoGen, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology